New asthma drug shows promise in Real-World spanish study

NCT ID NCT06487065

Completed Disease control Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well tezepelumab works for people with severe asthma when used in everyday medical practice, outside of a clinical trial. Researchers tracked 33 patients in Spain who received the drug through a special access program. The goal was to see how the drug affected asthma attacks, lung function, and other health measures over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEVERE ASTHMA

Contacts and locations

Locations

Research Site

Alcázar de San Juan, Spain
Research Site

Almería, Spain
Research Site

Badajoz, Spain
Research Site

Bilbao, Spain
Research Site

Coslada, Spain
Research Site

Donostia / San Sebastian, Spain
Research Site

Fuenlabrada, Spain
Research Site

Gran Canaria, Spain
Research Site

Lugo, Spain
Research Site

Madrid, Spain
Research Site

Málaga, Spain
Research Site

Talavera de la Reina, Spain
Research Site

Torrejón de Ardoz, Spain
Research Site

Valencia, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.